043100 — Solco Biomedical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩32bn
- KR₩49bn
- KR₩27bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18,788 | 1,637 | -4,179 | -7,765 | -21,398 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 13,467 | -633 | -389 | 1,536 | 9,545 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,963 | -6,000 | -1,909 | -414 | 1,580 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -6,739 | -3,980 | -5,411 | -5,463 | -9,044 |
Capital Expenditures | -1,524 | -1,446 | -844 | -916 | -1,458 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2,176 | 5,305 | 7,169 | 2,936 | 3,301 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 652 | 3,859 | 6,325 | 2,020 | 1,843 |
Financing Cash Flow Items | — | — | -9.34 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.26 | -238 | 1,807 | 1,977 | 5,858 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6,106 | -387 | 2,691 | -1,464 | -1,338 |